Literature DB >> 21344419

Are patient-reported voice outcomes better after surgery or after radiation for treatment of T1 glottic carcinoma?

Stephanie Misono1, Albert L Merati.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21344419      PMCID： PMC5813799          DOI： 10.1002/lary.21432

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  5 in total

Review 1.  Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision.

Authors:  Seth M Cohen; C Gaelyn Garrett; William D Dupont; Robert H Ossoff; Mark S Courey
Journal:  Ann Otol Rhinol Laryngol       Date:  2006-08       Impact factor: 1.547

Review 2.  Management of early-stage laryngeal cancer.

Authors:  Nishant Agrawal; Patrick K Ha
Journal:  Otolaryngol Clin North Am       Date:  2008-08       Impact factor: 3.346

3.  Voice-related quality of life after treatment of laryngeal cancer.

Authors:  Nobuhiko Oridate; Akihiro Homma; Seigo Suzuki; Yuji Nakamaru; Fumiyuki Suzuki; Hiromitsu Hatakeyama; Shigenari Taki; Tomohiro Sakashita; Noriko Nishizawa; Yasushi Furuta; Satoshi Fukuda
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-04

4.  Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy.

Authors:  Elisabeth V Sjögren; Maya A van Rossum; Ton P M Langeveld; Marika S Voerman; Vivienne A H van de Kamp; Mark O W Friebel; Ron Wolterbeek; Robert J Baatenburg de Jong
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-09

5.  Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index.

Authors:  Faustino Núñez Batalla; Maria Jesús Caminero Cueva; Blanca Señaris González; José Luis Llorente Pendás; Carmen Gorriz Gil; Aurora López Llames; Ramón Alonso Pantiga; Carlos Suárez Nieto
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-13       Impact factor: 2.503
  5 in total
  1 in total

1.  Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.

Authors:  Mohammad K Khan; Shlomo A Koyfman; Grant K Hunter; Chandana A Reddy; Jerrold P Saxton
Journal:  Radiat Oncol       Date:  2012-11-19       Impact factor: 3.481
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.